https://nintedanibethanesulfon....ate.com/results-of-t
However, there are no sufficient information and no constant international treatment recommendations encouraging a ketogenic diet as an adjuvant therapy for metastatic breast cancer. Therefore, this test had been built to observe whether irinotecan with a ketogenic diet can market susceptibility to chemotherapy and remit target lesions in locally recurrent or metastatic Her-2-negative cancer of the breast clients. Methods/design This trial aims to hire 518 women with locally recurrent or metastatic brea
Curtir
Comentario
Compartilhar
